New Medicon Pharma Lab Private Limited, a active private limited company, was established on 30 March 2006 in Chennai, Tamil Nadu, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U51397TN2006PTC059372. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹1.20 Cr and a paid-up capital of ₹5.73 M.
It upholds a compliant status. Employing 4 professional, Its leadership includes Selvaraj Santha Kumar (Director), Harinath Harinath (Director). Past directors included Raja, Prashant Gopisetty, Kasmal Abdul Sujathali. It holds ₹6.02 Cr open charges and ₹5.50 M settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at No 304/174 1St Floor, Ttk Road, Alwarpet (Landmark: Rajpark Hotel), Chennai, Tamil Nadu, 600018.
U51397TN2006PTC059372
059372
30 March 2006
₹1.20 Cr
₹5.73 M
Roc Chennai
Unlisted
Active
Explore comprehensive insights into New Medicon Pharma Lab Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Selvaraj Santha Kumar | Director | 30 Mar 2007 | Current |
| Harinath Harinath | Director | 30 Mar 2006 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 10 Jun 2019 | Past |
| Pramod Abcsdd | Director | 01 Apr 2011 | Past |
| Pramod Abcsdd | Director | 25 Mar 2010 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
New Medicon Pharma Lab Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 24.43% decrease. The company also saw a substantial fall in profitability, with a 63.11% decrease in profit. The company's net worth moved up by a moderate rise of 8.14%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, New Medicon Pharma Lab had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹60,161,000.00
₹5,500,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 02 Jul 2024 | Canara Bank | ₹4.04 Cr | Open |
| 29 Jun 2021 | Indian Bank | ₹1.98 Cr | Open |
| 12 Jun 2007 | Indian Bank | ₹5.50 M | Satisfied |
Explore comprehensive loan charge details -
New Medicon Pharma Lab has a workforce of 4 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of New Medicon Pharma Lab, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped New Medicon Pharma Lab's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on New Medicon Pharma Lab Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Progress on A charge with Canara Bank amounted to Rs. 4.04 Cr with Charge ID 100959682 was registered on 02 Jul 2024. was documented.
Progress on New Medicon Pharma Lab Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chennai. was documented.
A charge with Indian Bank amounted to Rs. 1.98 Cr with Charge ID 100456992 was registered on 29 Jun 2021. was recorded as a recent event.
A charge registered on 12 Jun 2007 via Charge ID 10058603 with Indian Bank was fully satisfied on 14 Aug 2020. was recorded as a recent event.
A charge with Indian Bank amounted to Rs. 0.55 Cr with Charge ID 10058603 was registered on 12 Jun 2007. was recorded as a recent event.
The CIN of New Medicon Pharma Lab Private Limited is U51397TN2006PTC059372.
New Medicon Pharma Lab Private Limited is headquartered at No 304/174 1St Floor, Ttk Road, Alwarpet (Landmark: Rajpark Hotel), Chennai, Tamil Nadu, 600018.
New Medicon Pharma Lab Private Limited was incorporated on 30 March 2006.
The current directors of New Medicon Pharma Lab Private Limited are
The primary industry of New Medicon Pharma Lab Private Limited is Trade.
New Medicon Pharma Lab Private Limited is unlisted.
The authorized capital of New Medicon Pharma Lab Private Limited is ₹1.20 Cr, and the paid-up capital is ₹5.73 M.
The compliance status of New Medicon Pharma Lab Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX